PVC - Premature Ventricular ComplexNCT04893278
Virtual Reality in Electrophysiology Laboratory (EP)
An observational study of PVC - Premature Ventricular Complex and Ablation, run by Mayo Clinic at 1 site in United States.
Trial summary
The purpose of this study is to evaluate the use of virtual reality (VR) technology as adjunct to routine anesthesia care for patients undergoing electrophysiology (EP) procedures. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- PVC - Premature Ventricular Complex, Ablation
- What is being tested?
- Virtual reality
- How many people
- 10 participants
- Where
- 1 siteUnited States
- Study dates
- 31 Jul 2021to Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Subjects will be selected from patients undergoing procedures under monitored anesthesia care.
Who may be able to join
- Age ≥ 18 years old.
- Patients scheduled for electrophysiology procedure with MAC.
- Subject willing to participate and able to provide informed consent.
Who cannot join
- Age < 18 years old.
- History of motion sickness or blindness.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Use of Virtual Reality as An Adjunct for Anesthesia During Procedures in the Electrophysiology Laboratory: A Pilot and Feasibility Study
The purpose of this study is to evaluate the use of virtual reality (VR) technology as adjunct to routine anesthesia care for patients undergoing electrophysiology (EP) procedures.
- Conditions
- PVC - Premature Ventricular Complex, Ablation
- Being tested
- Virtual reality
- Keywords
- virtual reality
- Medical subject headings
- Ventricular Premature Complexes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Virtual realityOther
Use of Virtual reality goggles during procedure
| Study group | Role | What they receive |
|---|---|---|
| Virtual reality | Not described Receives: Other: Virtual reality |
What is being measured
The primary outcome is the main question the study is designed to answer.
Virtual reality as distractor
Evaluate patients' experience and satisfaction with using virutal reality during electrophysiology procedures
Measured: Up to 2hours
Secondary outcomes (2)
Impact of virtual reality use on pharmacological therapy
Evalute the amount of medications use during the procedure
Measured: Up to 2 hours
Impact of virtual reality on electrophysilogy procedure
Evaluate success rate of completing ablation while patient is utilizing virtual reality
Measured: Up to 2 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 May 2021
- Study start31 Jul 2021
- Primary completionDec 2026 (estimated)
- Study completionDec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PVC - Premature Ventricular ComplexStudies of the same condition, open and under way.
- More trials run by Mayo ClinicThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mayo Clinic
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Klaus D. Torp, Mayo Clinic
- Investigators
- Klaus Torp, MD, Principal investigator, Mayo Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04893278
- Sponsor's protocol ID
- 21-002644
- Status last verified
- Jan 2026
- First submitted
- 14 May 2021
- Last updated
- 21 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Use of Virtual Reality as An Adjunct for Anesthesia During Procedures in the Electrophysiology Laboratory: A Pilot and Feasibility Study
- ClinicalTrials.gov ID
- NCT04893278
- Acronym / sponsor ID
- 21-002644
- Conditions
- PVC - Premature Ventricular Complex, Ablation
- Keywords
- virtual reality
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 10 participants (estimated)
- Lead sponsor
- Mayo ClinicUniversity, hospital or other
- Study start
- 31 Jul 2021 (actual)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Dec 2026 (estimated)
- First posted
- 19 May 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate the use of virtual reality (VR) technology as adjunct to routine anesthesia care for patients undergoing electrophysiology (EP) procedures.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Virtual reality | – | Other: Virtual reality |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Subjects will be selected from patients undergoing procedures under monitored anesthesia care.
Key inclusion criteria (3 listed)
- Age ≥ 18 years old.
- Patients scheduled for electrophysiology procedure with MAC.
- Subject willing to participate and able to provide informed consent.
Key exclusion criteria (2 listed)
- Age < 18 years old.
- History of motion sickness or blindness.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Virtual realityUse of Virtual reality goggles during procedure | Other | Virtual reality |
Primary outcome
Virtual reality as distractor
Time frame: Up to 2hours
Evaluate patients' experience and satisfaction with using virutal reality during electrophysiology procedures
2 secondary outcomes
Impact of virtual reality use on pharmacological therapy
Time frame: Up to 2 hours
Impact of virtual reality on electrophysilogy procedure
Time frame: Up to 2 hours
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jan 2026.
- Mayo Clinic Clinical TrialsLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for PVC - Premature Ventricular Complex
RecruitingObservational study
AI-Based Differential Diagnosis and Localization of Tachycardia Using ECG: Multicenter Registry (EP-AI ASSIST)
Tachycardia, Paroxysmal Supraventricular Tachycardia
Not yet recruitingObservational study
Premature Ventricular Complex and Diet Inflamatuar Index
Premature Ventricular Complexes, Diet Quality
Recruiting
Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
Obstructive Sleep Apnea, Premature Ventricular Contraction (PVC)
Recruiting
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
Scar-related Atrial Tachycardia, Persistent Atrial Fibrillation
Recruiting
Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes
Premature Ventricular Complexes, Premature Ventricular Contraction (PVC)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Klaus Torp, MD principal investigator
Mayo Clinic
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of PVC - Premature Ventricular Complex and Ablation, run by Mayo Clinic at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 21 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Virtual reality as distractor (time frame: Up to 2hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2026.